Fifth Third Bancorp Teva Pharmaceutical Industries LTD Transaction History

Fifth Third Bancorp

$27.3 Billion
Q3 2024

A detailed history of Fifth Third Bancorp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Fifth Third Bancorp holds 276 shares of TEVA stock, worth $4,725. This represents 0.0% of its overall portfolio holdings.

Number of Shares

276

Previous 276 -0.0%

Holding current value

$4,725

Previous $4,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$12.78 - $17.4 $651 - $887	51 Added 22.67%	276 $4,000
Q4 2023 Jan 19, 2024	SELL	$8.12 - $10.63 $576 - $754	-71 Reduced 23.99%	225 $2,000
Q3 2023 Oct 31, 2023	SELL	$7.48 - $10.7 $987 - $1,412	-132 Reduced 30.84%	296 $3,000
Q2 2023 Jul 25, 2023	SELL	$7.2 - $9.47 $417 - $549	-58 Reduced 11.93%	428 $3,000
Q1 2023 Apr 24, 2023	BUY	$8.36 - $11.37 $3,360 - $4,570	402 Added 478.57%	486 $4,000
Q4 2022 Jan 25, 2023	SELL	$7.95 - $9.48 $8,101 - $9,660	-1,019 Reduced 92.38%	84 $0
Q3 2022 Oct 25, 2022	BUY	$6.86 - $11.95 $397 - $693	58 Added 5.55%	1,103 $9,000
Q2 2022 Aug 04, 2022	SELL	$7.38 - $10.4 $590 - $832	-80 Reduced 7.11%	1,045 $8,000
Q1 2022 Apr 19, 2022	BUY	$7.33 - $9.39 $586 - $751	80 Added 7.66%	1,125 $11,000
Q4 2021 Feb 01, 2022	SELL	$7.9 - $10.19 $4,305 - $5,553	-545 Reduced 34.28%	1,045 $8,000
Q3 2021 Oct 15, 2021	SELL	$8.38 - $10.18 $467,226 - $567,585	-55,755 Reduced 97.23%	1,590 $15,000
Q2 2021 Aug 06, 2021	BUY	$9.9 - $11.56 $24,670 - $28,807	2,492 Added 4.54%	57,345 $568,000
Q1 2021 May 07, 2021	BUY	$10.34 - $12.81 $289,520 - $358,680	28,000 Added 104.27%	54,853 $633,000
Q4 2020 Feb 16, 2021	BUY	$8.61 - $11.04 $8,997 - $11,536	1,045 Added 4.05%	26,853 $259,000
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $95,664 - $157,048	14,650 Added 131.3%	25,808 $253,000
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $18,788 - $29,280	-3,050 Reduced 21.47%	11,158 $77,000
Q2 2019 Aug 07, 2019	BUY	$8.12 - $15.72 $38,732 - $74,984	4,770 Added 50.54%	14,208 $131,000
Q1 2019 May 14, 2019	BUY	$15.58 - $20.01 $42,564 - $54,667	2,732 Added 40.74%	9,438 $148,000
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $13,641 - $22,290	-935 Reduced 12.24%	6,706 $103,000
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $153,843 - $187,373	-7,305 Reduced 48.88%	7,641 $165,000
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $27,804 - $40,969	1,658 Added 12.48%	14,946 $363,000
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $104,967 - $138,886	-6,293 Reduced 32.14%	13,288 $227,000
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $114,972 - $195,545	-10,238 Reduced 34.33%	19,581 $371,000
Q3 2017 Nov 14, 2017	SELL	$15.41 - $32.17 $102,476 - $213,930	-6,650 Reduced 18.23%	29,819 $525,000
Q2 2017 Aug 11, 2017	BUY	N/A	36,469	36,469 $1.21 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Teva Pharmaceutical Industries LTD Transaction History